COVID-19 mortality risk in Down syndrome: results from a cohort study of 8 million adults

AK Clift, CAC Coupland, RH Keogh… - Annals of internal …, 2021 - acpjournals.org
Background: At the start of the coronavirus disease 2019 (COVID-19) pandemic, many
national health organizations emphasized nonpharmacologic interventions, such as …
被引用次数：224 相关文章

COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults

AK Clift, CAC Coupland, RH Keogh… - Annals of Internal …, 2021 - discovery.ucl.ac.uk
Background: At the start of the coronavirus disease 2019 (COVID-19) pandemic, many
national health organizations emphasized nonpharmacologic interventions, such as …

[引用][C] COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults

AK Clift, CAC Coupland, RH Keogh… - Annals of internal …, 2021 - pubmed.ncbi.nlm.nih.gov
COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults
COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults …

COVID-19 mortality risk in down syndrome: results from a cohort study of 8 million adults.

AK Clift, CAC Coupland, RH Keogh, H Hemingway… - 2021 - cabidigitallibrary.org
The objective of this study was to evaluate Down syndrome as a risk factor for death from
COVID-19 through a comprehensive analysis of individual-level data in a cohort study of …
[PDF] paediatrieschweiz.ch

[PDF][PDF] OBSERVATION: BRIEF RESEARCH REPORT

2020 - cdn.paediatrieschweiz.ch
Background: At the start of the coronavirus disease 2019 (COVID-19) pandemic, many
national health organizations emphasized nonpharmacologic interventions, such as …

[引用][C] COVID-19 mortality risk in Down syndrome: results from a cohort study of 8 million adults

AK Clift, CAC Coupland, RH Keogh… - Annals of Internal …, 2020 - ora.ox.ac.uk
COVID-19 mortality risk in Down syndrome: results from a cohort study of 8 million adults - ORA
- Oxford University Research Archive Logos Header links Search History Bookmarks 0 New …
[PDF] mensch21.ch

[PDF][PDF] OBSERVATION: BRIEF RESEARCH REPORT

2020 - mensch21.ch
Background: At the start of the coronavirus disease 2019 (COVID-19) pandemic, many
national health organizations emphasized nonpharmacologic interventions, such as …
[HTML] nih.gov

[HTML][HTML] COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults

AK Clift, CAC Coupland, RH Keogh… - Annals of Internal … - ncbi.nlm.nih.gov
Background: At the start of the coronavirus disease 2019 (COVID-19) pandemic, many
national health organizations emphasized nonpharmacologic interventions, such as …

COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults.

AK Clift, CAC Coupland, RH Keogh… - Annals of Internal …, 2020 - europepmc.org
Background: At the start of the coronavirus disease 2019 (COVID-19) pandemic, many
national health organizations emphasized nonpharmacologic interventions, such as …

COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults.

AK Clift, CAC Coupland, RH Keogh… - Annals of Internal …, 2020 - europepmc.org
Background: At the start of the coronavirus disease 2019 (COVID-19) pandemic, many
national health organizations emphasized nonpharmacologic interventions, such as …